Pathway
|
Identified node
|
p-value
|
q-value
|
BioCarta//Hs_ADP-Ribosylation Factor
|
9/21 (57)
|
0.0003
|
0.0219
|
BioCarta//Hs_CTCF: First Multivalent Nuclear Factor
|
9/23 (26)
|
0.0007
|
0.0246
|
BioCarta//Hs_Apoptotic Signaling in Response to DNA Damage
|
7/21 (29)
|
0.0079
|
0.1483
|
BioCarta//Hs_Regulation of eIF2
|
4/9 (20)
|
0.0148
|
0.1483
|
BioCarta//Hs_Phospholipase C d1 in phospholipid associated cell signaling
|
3/5 (10)
|
0.0136
|
0.1483
|
BioCarta//Hs_Attenuation of GPCR Signaling
|
5/13 (13)
|
0.0128
|
0.1483
|
BioCarta//Hs_Ion Channel and Phorbal Esters Signaling Pathway
|
3/5 (7)
|
0.0136
|
0.1590
|
BioCarta//Hs_Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)
|
11/54 (64)
|
0.0464
|
0.1600
|
BioCarta//Hs_Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to fa
|
5/15 (28)
|
0.0245
|
0.1600
|
BioCarta//Hs_Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway
|
5/20 (23)
|
0.0777
|
0.1600
|
BioCarta//Hs_WNT Signaling Pathway
|
6/25 (42)
|
0.0656
|
0.1600
|
BioCarta//Hs_Role of Tob in T-cell activation
|
6/19 (30)
|
0.0183
|
0.1600
|
BioCarta//Hs_Degradation of the RAR and RXR by the proteasome
|
2/3 (11)
|
0.0386
|
0.1600
|
BioCarta//Hs_Transcription Regulation by Methyltransferase of CARM1
|
4/13 (34)
|
0.0576
|
0.1600
|
BioCarta//Hs_ATM Signaling Pathway
|
5/19 (32)
|
0.0642
|
0.1600
|
BioCarta//Hs_Regulation of eIF4e and p70 S6 Kinase
|
6/24 (37)
|
0.0551
|
0.1600
|
BioCarta//Hs_Phospholipase C-epsilon pathway
|
4/12 (25)
|
0.0438
|
0.1600
|
BioCarta//Hs_Inhibition of Matrix Metalloproteinases
|
3/9 (15)
|
0.0800
|
0.1600
|
BioCarta//Hs_Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy
|
5/18 (31)
|
0.0521
|
0.1600
|
BioCarta//Hs_Signaling Pathway from G-Protein Families
|
8/34 (42)
|
0.0398
|
0.1600
|
BioCarta//Hs_cdc25 and chk1 Regulatory Pathway in response to DNA damage
|
3/9 (13)
|
0.0800
|
0.1600
|
BioCarta//Hs_Transcription factor CREB and its extracellular signals
|
6/26 (26)
|
0.0773
|
0.1600
|
BioCarta//Hs_Activation of PKC through G protein coupled receptor
|
3/7 (8)
|
0.0398
|
0.1600
|
BioCarta//Hs_Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes
|
5/17 (20)
|
0.0415
|
0.1600
|
BioCarta//Hs_Spliceosomal Assembly
|
4/14 (14)
|
0.0734
|
0.1600
|
BioCarta//Hs_Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells
|
6/26 (43)
|
0.0773
|
0.1690
|
BioCarta//Hs_Bone Remodelling
|
4/14 (19)
|
0.0734
|
0.1713
|
BioCarta//Hs_B Cell Survival Pathway
|
4/14 (16)
|
0.0734
|
0.1713
|
BioCarta//Hs_TACI and BCMA stimulation of B cell immune responses.
|
4/14 (21)
|
0.0734
|
0.1713
|
BioCarta//Hs_Cadmium induces DNA synthesis and proliferation in macrophages
|
4/15 (21)
|
0.0912
|
0.1752
|
BioCarta//Hs_Nitric Oxide Signaling Pathway
|
5/21 (25)
|
0.0926
|
0.1752
|
BioCarta//Hs_Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages
|
6/25 (42)
|
0.0656
|
0.1767
|
BioCarta//Hs_Rab GTPases Mark Targets In The Endocytotic Machinery
|
4/12 (17)
|
0.0438
|
0.1804
|
BioCarta//Hs_Cystic fibrosis transmembrane conductance regulator and beta 2 adrenergic receptor pathway
|
4/12 (37)
|
0.0438
|
0.1804
|
BioCarta//Hs_Double Stranded RNA Induced Gene Expression
|
3/10 (14)
|
0.1047
|
0.1832
|
BioCarta//Hs_Erk1/Erk2 Mapk Signaling pathway
|
6/28 (33)
|
0.1038
|
0.1832
|
BioCarta//Hs_RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage
|
4/13 (17)
|
0.0576
|
0.1833
|
BioCarta//Hs_p53 Signaling Pathway
|
4/16 (27)
|
0.1108
|
0.1847
|
BioCarta//Hs_Role of MEF2D in T-cell Apoptosis
|
4/16 (45)
|
0.1108
|
0.1847
|
BioCarta//Hs_Cell Cycle: G1/S Check Point
|
6/28 (34)
|
0.1038
|
0.1863
|
BioCarta//Hs_ChREBP regulation by carbohydrates and cAMP
|
5/19 (30)
|
0.0642
|
0.1872
|
BioCarta//Hs_CCR3 signaling in Eosinophils
|
5/23 (30)
|
0.1264
|
0.1928
|
BioCarta//Hs_Map Kinase Inactivation of SMRT Corepressor
|
3/11 (14)
|
0.1319
|
0.1928
|
BioCarta//Hs_Y branching of actin filaments
|
4/17 (45)
|
0.1322
|
0.1928
|
BioCarta//Hs_Regulation of ck1/cdk5 by type 1 glutamate receptors
|
4/17 (38)
|
0.1322
|
0.1928
|
BioCarta//Hs_Corticosteroids and cardioprotection
|
4/17 (28)
|
0.1322
|
0.1928
|
BioCarta//Hs_Telomeres, Telomerase, Cellular Aging, and Immortality
|
4/18 (31)
|
0.1551
|
0.2010
|
BioCarta//Hs_mTOR Signaling Pathway
|
5/24 (44)
|
0.1452
|
0.2010
|
BioCarta//Hs_Effects of calcineurin in Keratinocyte Differentiation
|
4/18 (36)
|
0.1551
|
0.2010
|
BioCarta//Hs_Visceral Fat Deposits and the Metabolic Syndrome
|
2/6 (9)
|
0.1519
|
0.2010
|
BioCarta//Hs_Role of Parkin in the Ubiquitin-Proteasomal Pathway
|
3/12 (38)
|
0.1612
|
0.2016
|
BioCarta//Hs_Trka Receptor Signaling Pathway
|
3/12 (12)
|
0.1612
|
0.2016
|
BioCarta//Hs_CXCR4 Signaling Pathway
|
5/24 (35)
|
0.1452
|
0.2032
|
BioCarta//Hs_SREBP control of lipid synthesis
|
2/6 (24)
|
0.1519
|
0.2045
|
BioCarta//Hs_AKAP95 role in mitosis and chromosome dynamics
|
3/11 (39)
|
0.1319
|
0.2052
|
BioCarta//Hs_Melanocyte Development and Pigmentation Pathway
|
3/7 (13)
|
0.0398
|
0.2145
|
BioCarta//Hs_TGF beta signaling pathway
|
4/19 (76)
|
0.1793
|
0.2202
|
BioCarta//Hs_ALK in cardiac myocytes
|
6/34 (51)
|
0.2067
|
0.2226
|
BioCarta//Hs_g-Secretase mediated ErbB4 Signaling Pathway
|
2/7 (19)
|
0.1967
|
0.2226
|
BioCarta//Hs_Extrinsic Prothrombin Activation Pathway
|
3/13 (24)
|
0.1923
|
0.2226
|
BioCarta//Hs_Acute Myocardial Infarction
|
4/20 (23)
|
0.2047
|
0.2226
|
BioCarta//Hs_mCalpain and friends in Cell motility
|
4/22 (38)
|
0.2582
|
0.2232
|
BioCarta//Hs_Aspirin Blocks Signaling Pathway Involved in Platelet Activation
|
4/22 (32)
|
0.2582
|
0.2232
|
BioCarta//Hs_Regulation of BAD phosphorylation
|
4/22 (31)
|
0.2582
|
0.2232
|
BioCarta//Hs_NFAT and Hypertrophy of the heart (Transcription in the broken heart)
|
8/51 (82)
|
0.2498
|
0.2232
|
BioCarta//Hs_Inhibition of Cellular Proliferation by Gleevec
|
4/22 (23)
|
0.2582
|
0.2232
|
BioCarta//Hs_T Cell Receptor Signaling Pathway
|
7/43 (56)
|
0.2400
|
0.2232
|
BioCarta//Hs_Regulation of cell cycle progression by Plk3
|
2/8 (17)
|
0.2428
|
0.2232
|
BioCarta//Hs_Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility
|
4/21 (25)
|
0.2311
|
0.2232
|
BioCarta//Hs_CD40L Signaling Pathway
|
3/15 (27)
|
0.2582
|
0.2232
|
BioCarta//Hs_Role of Mitochondria in Apoptotic Signaling
|
4/20 (38)
|
0.2047
|
0.2239
|
BioCarta//Hs_Oxidative Stress Induced Gene Expression Via Nrf2
|
4/20 (24)
|
0.2047
|
0.2239
|
BioCarta//Hs_Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor
|
4/20 (24)
|
0.2047
|
0.2239
|
BioCarta//Hs_Cell to Cell Adhesion Signaling
|
3/13 (14)
|
0.1923
|
0.2282
|
BioCarta//Hs_Sonic Hedgehog (Shh) Pathway
|
3/16 (29)
|
0.2922
|
0.2324
|
BioCarta//Hs_How Progesterone Initiates the Oocyte Maturation
|
5/30 (32)
|
0.2774
|
0.2324
|
BioCarta//Hs_Polyadenylation of mRNA
|
2/9 (35)
|
0.2894
|
0.2324
|
BioCarta//Hs_Intrinsic Prothrombin Activation Pathway
|
4/23 (36)
|
0.2860
|
0.2324
|
BioCarta//Hs_Feeder Pathways for Glycolysis
|
2/9 (11)
|
0.2894
|
0.2328
|
BioCarta//Hs_Erythrocyte Differentiation Pathway
|
3/15 (21)
|
0.2582
|
0.2347
|
BioCarta//Hs_Endocytotic role of NDK, Phosphins and Dynamin
|
3/15 (48)
|
0.2582
|
0.2347
|
BioCarta//Hs_The information-processing pathway at the IFN-beta enhancer
|
3/15 (27)
|
0.2582
|
0.2347
|
BioCarta//Hs_Eukaryotic protein translation
|
3/15 (20)
|
0.2582
|
0.2347
|
BioCarta//Hs_PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase
|
3/15 (18)
|
0.2582
|
0.2347
|
BioCarta//Hs_Phosphoinositides and their downstream targets.
|
4/23 (23)
|
0.2860
|
0.2355
|
BioCarta//Hs_TPO Signaling Pathway
|
4/23 (54)
|
0.2860
|
0.2355
|
BioCarta//Hs_IL 6 signaling pathway
|
4/21 (48)
|
0.2311
|
0.2414
|
BioCarta//Hs_Cell Cycle: G2/M Checkpoint
|
4/24 (27)
|
0.3141
|
0.2423
|
BioCarta//Hs_Nitrogen-depedent regulation of Rtg1 and Rtg3 in TOR pathway
|
1/3 (8)
|
0.3149
|
0.2423
|
BioCarta//Hs_Phospholipase C Signaling Pathway
|
2/8 (12)
|
0.2428
|
0.2428
|
BioCarta//Hs_NFkB activation by Nontypeable Hemophilus influenzae
|
4/24 (43)
|
0.3141
|
0.2443
|
BioCarta//Hs_Induction of apoptosis through DR3 and DR4/5 Death Receptors
|
5/32 (37)
|
0.3263
|
0.2457
|
BioCarta//Hs_CDK Regulation of DNA Replication
|
3/17 (56)
|
0.3264
|
0.2457
|
BioCarta//Hs_Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia
|
2/22 (40)
|
0.7548
|
0.2469
|
BioCarta//Hs_HIV-I Nef: negative effector of Fas and TNF
|
7/57 (77)
|
0.5213
|
0.2469
|
BioCarta//Hs_Integrin Signaling Pathway
|
4/37 (45)
|
0.6552
|
0.2469
|
BioCarta//Hs_Phospholipids as signalling intermediaries
|
3/25 (42)
|
0.5831
|
0.2469
|
BioCarta//Hs_Signaling of Hepatocyte Growth Factor Receptor
|
5/36 (42)
|
0.4256
|
0.2469
|
BioCarta//Hs_Trefoil Factors Initiate Mucosal Healing
|
3/24 (95)
|
0.5542
|
0.2469
|
BioCarta//Hs_VEGF, Hypoxia, and Angiogenesis
|
4/28 (34)
|
0.4276
|
0.2469
|
BioCarta//Hs_Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling
|
4/33 (44)
|
0.5614
|
0.2469
|
BioCarta//Hs_Caspase Cascade in Apoptosis
|
2/22 (27)
|
0.7548
|
0.2469
|
BioCarta//Hs_CARM1 and Regulation of the Estrogen Receptor
|
3/26 (33)
|
0.6108
|
0.2469
|
BioCarta//Hs_Deregulation of CDK5 in Alzheimers Disease
|
2/10 (16)
|
0.3355
|
0.2469
|
BioCarta//Hs_Rho cell motility signaling pathway
|
4/30 (32)
|
0.4828
|
0.2469
|
BioCarta//Hs_MAPKinase Signaling Pathway
|
10/85 (88)
|
0.5618
|
0.2469
|
BioCarta//Hs_Keratinocyte Differentiation
|
5/46 (67)
|
0.6517
|
0.2469
|
BioCarta//Hs_Synaptic Proteins at the Synaptic Junction
|
3/20 (32)
|
0.4283
|
0.2469
|
BioCarta//Hs_Growth Hormone Signaling Pathway
|
4/26 (35)
|
0.3710
|
0.2469
|
BioCarta//Hs_IL 2 signaling pathway
|
3/22 (47)
|
0.4932
|
0.2469
|
BioCarta//Hs_IL-2 Receptor Beta Chain in T cell Activation
|
4/35 (38)
|
0.6100
|
0.2469
|
BioCarta//Hs_fMLP induced chemokine gene expression in HMC-1 cells
|
4/36 (58)
|
0.6330
|
0.2469
|
BioCarta//Hs_BCR Signaling Pathway
|
5/34 (54)
|
0.3759
|
0.2469
|
BioCarta//Hs_Links between Pyk2 and Map Kinases
|
3/28 (44)
|
0.6624
|
0.2469
|
BioCarta//Hs_PDGF Signaling Pathway
|
3/27 (61)
|
0.6372
|
0.2469
|
BioCarta//Hs_Thrombin signaling and protease-activated receptors
|
3/21 (31)
|
0.4611
|
0.2469
|
BioCarta//Hs_CBL mediated ligand-induced downregulation of EGF receptors
|
2/13 (51)
|
0.4670
|
0.2469
|
BioCarta//Hs_Bioactive Peptide Induced Signaling Pathway
|
4/38 (58)
|
0.6764
|
0.2469
|
BioCarta//Hs_NF-kB Signaling Pathway
|
3/23 (49)
|
0.5242
|
0.2469
|
BioCarta//Hs_TNFR2 Signaling Pathway
|
2/18 (32)
|
0.6478
|
0.2469
|
BioCarta//Hs_Signal transduction through IL1R
|
3/30 (41)
|
0.7088
|
0.2469
|
BioCarta//Hs_Acetylation and Deacetylation of RelA in The Nucleus
|
2/16 (34)
|
0.5819
|
0.2469
|
BioCarta//Hs_Fibrinolysis Pathway
|
2/11 (14)
|
0.3808
|
0.2469
|
BioCarta//Hs_Ras Signaling Pathway
|
2/22 (23)
|
0.7548
|
0.2469
|
BioCarta//Hs_IGF-1 Signaling Pathway
|
2/20 (45)
|
0.7053
|
0.2469
|
BioCarta//Hs_Platelet Amyloid Precursor Protein Pathway
|
2/14 (15)
|
0.5073
|
0.2469
|
BioCarta//Hs_Lissencephaly gene (LIS1) in neuronal migration and development
|
2/19 (48)
|
0.6776
|
0.2469
|
BioCarta//Hs_Role of ?arrestins in the activation and targeting of MAP kinases
|
2/17 (40)
|
0.6159
|
0.2469
|
BioCarta//Hs_Roles of ?arrestin-dependent Recruitment of Src Kinases in GPCR Signaling
|
2/21 (34)
|
0.7310
|
0.2469
|
BioCarta//Hs_beta-arrestins in GPCR Desensitization
|
2/15 (40)
|
0.5457
|
0.2469
|
BioCarta//Hs_Signal Dependent Regulation of Myogenesis by Corepressor MITR
|
1/9 (25)
|
0.6792
|
0.2469
|
BioCarta//Hs_Blockade of Neurotransmitter Relase by Botulinum Toxin
|
1/5 (28)
|
0.4679
|
0.2469
|
BioCarta//Hs_BRCA1-dependent Ub-ligase activity
|
1/8 (18)
|
0.6359
|
0.2469
|
BioCarta//Hs_The PRC2 Complex sets Long-term gene Silencing The Modification of Histone Tails
|
2/12 (20)
|
0.4247
|
0.2469
|
BioCarta//Hs_Eph Kinases and ephrins support platelet aggregation
|
1/10 (17)
|
0.7174
|
0.2469
|
BioCarta//Hs_Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation
|
1/11 (35)
|
0.7511
|
0.2469
|
BioCarta//Hs_Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline
|
1/6 (6)
|
0.5311
|
0.2469
|
BioCarta//Hs_The reactions that feed amino groups into the urea cycle
|
1/7 (16)
|
0.5868
|
0.2469
|
BioCarta//Hs_Generation of amyloid b-peptide by PS1
|
1/4 (9)
|
0.3962
|
0.2469
|
BioCarta//Hs_Toll-Like Receptor Pathway
|
3/34 (45)
|
0.7869
|
0.2481
|
BioCarta//Hs_Nuclear Receptors in Lipid Metabolism and Toxicity
|
3/34 (43)
|
0.7869
|
0.2481
|
BioCarta//Hs_Stathmin and breast cancer resistance to antimicrotubule agents
|
2/23 (26)
|
0.7768
|
0.2481
|
BioCarta//Hs_Lectin Induced Complement Pathway
|
1/12 (56)
|
0.7808
|
0.2481
|
BioCarta//Hs_IL22 Soluble Receptor Signaling Pathway
|
1/12 (40)
|
0.7808
|
0.2484
|
BioCarta//Hs_Gamma-aminobutyric Acid Receptor Life Cycle
|
1/12 (73)
|
0.7808
|
0.2484
|
BioCarta//Hs_Ca++/ Calmodulin-dependent Protein Kinase Activation
|
1/12 (76)
|
0.7808
|
0.2484
|
BioCarta//Hs_Ghrelin: Regulation of Food Intake and Energy Homeostasis
|
1/11 (30)
|
0.7511
|
0.2492
|
BioCarta//Hs_Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle
|
1/11 (30)
|
0.7511
|
0.2492
|
BioCarta//Hs_Prion Pathway
|
1/11 (11)
|
0.7511
|
0.2492
|
BioCarta//Hs_BTG family proteins and cell cycle regulation
|
1/11 (13)
|
0.7511
|
0.2492
|
BioCarta//Hs_Erythropoietin mediated neuroprotection through NF-kB
|
1/11 (17)
|
0.7511
|
0.2492
|
BioCarta//Hs_Vitamin C in the Brain
|
1/11 (20)
|
0.7511
|
0.2492
|
BioCarta//Hs_Control of Gene Expression by Vitamin D Receptor
|
2/24 (32)
|
0.7970
|
0.2502
|
BioCarta//Hs_AKT Signaling Pathway
|
2/21 (32)
|
0.7310
|
0.2508
|
BioCarta//Hs_Rac 1 cell motility signaling pathway
|
2/21 (23)
|
0.7310
|
0.2508
|
BioCarta//Hs_Insulin Signaling Pathway
|
2/21 (48)
|
0.7310
|
0.2508
|
BioCarta//Hs_Sumoylation by RanBP2 Regulates Transcriptional Repression
|
1/10 (25)
|
0.7174
|
0.2511
|
BioCarta//Hs_Electron Transport Reaction in Mitochondria
|
1/10 (10)
|
0.7174
|
0.2511
|
BioCarta//Hs_Glycolysis Pathway
|
1/10 (21)
|
0.7174
|
0.2511
|
BioCarta//Hs_Free Radical Induced Apoptosis
|
1/10 (11)
|
0.7174
|
0.2511
|
BioCarta//Hs_Regulators of Bone Mineralization
|
1/10 (57)
|
0.7174
|
0.2511
|
BioCarta//Hs_Reversal of Insulin Resistance by Leptin
|
1/10 (11)
|
0.7174
|
0.2511
|
BioCarta//Hs_Apoptotic DNA fragmentation and tissue homeostasis
|
1/10 (15)
|
0.7174
|
0.2511
|
BioCarta//Hs_Mechanism of Protein Import into the Nucleus
|
1/9 (19)
|
0.6792
|
0.2516
|
BioCarta//Hs_Lck and Fyn tyrosine kinases in initiation of TCR Activation
|
1/9 (16)
|
0.6792
|
0.2516
|
BioCarta//Hs_Role of PPAR-gamma Coactivators in Obesity and Thermogenesis
|
1/9 (12)
|
0.6792
|
0.2516
|
BioCarta//Hs_B Lymphocyte Cell Surface Molecules
|
1/9 (10)
|
0.6792
|
0.2516
|
BioCarta//Hs_Visual Signal Transduction
|
1/9 (12)
|
0.6792
|
0.2516
|
BioCarta//Hs_Regulation of PGC-1a
|
2/23 (31)
|
0.7768
|
0.2517
|
BioCarta//Hs_ER-associated degradation (ERAD) Pathway
|
1/13 (20)
|
0.8069
|
0.2522
|
BioCarta//Hs_Influence of Ras and Rho proteins on G1 to S Transition
|
2/26 (33)
|
0.8327
|
0.2543
|
BioCarta//Hs_p38 MAPK Signaling Pathway
|
3/38 (40)
|
0.8469
|
0.2543
|
BioCarta//Hs_Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK)
|
2/28 (41)
|
0.8626
|
0.2543
|
BioCarta//Hs_Chaperones modulate interferon Signaling Pathway
|
1/16 (34)
|
0.8682
|
0.2543
|
BioCarta//Hs_Human Cytomegalovirus and Map Kinase Pathways
|
1/16 (17)
|
0.8682
|
0.2543
|
BioCarta//Hs_Downregulated of MTA-3 in ER-negative Breast Tumors
|
1/16 (23)
|
0.8682
|
0.2543
|
BioCarta//Hs_Steps in the Glycosylation of Mammalian N-linked Oligosaccarides
|
1/16 (16)
|
0.8682
|
0.2543
|
BioCarta//Hs_Adhesion and Diapedesis of Lymphocytes
|
1/14 (47)
|
0.8300
|
0.2543
|
BioCarta//Hs_Adhesion and Diapedesis of Granulocytes
|
1/15 (49)
|
0.8503
|
0.2543
|
BioCarta//Hs_Role of nicotinic acetylcholine receptors in the regulation of apoptosis
|
1/15 (24)
|
0.8503
|
0.2544
|
BioCarta//Hs_IL 17 Signaling Pathway
|
1/15 (16)
|
0.8503
|
0.2544
|
BioCarta//Hs_Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation
|
1/15 (29)
|
0.8503
|
0.2544
|
BioCarta//Hs_The IGF-1 Receptor and Longevity
|
1/14 (14)
|
0.8300
|
0.2548
|
BioCarta//Hs_Stress Induction of HSP Regulation
|
1/14 (22)
|
0.8300
|
0.2548
|
BioCarta//Hs_Classical Complement Pathway
|
1/14 (68)
|
0.8300
|
0.2548
|
BioCarta//Hs_Selective expression of chemokine receptors during T-cell polarization
|
2/29 (55)
|
0.8757
|
0.2554
|
BioCarta//Hs_Actions of Nitric Oxide in the Heart
|
2/30 (44)
|
0.8876
|
0.2576
|
BioCarta//Hs_The 4-1BB-dependent immune response
|
1/18 (22)
|
0.8978
|
0.2576
|
BioCarta//Hs_Nerve growth factor pathway (NGF)
|
1/18 (38)
|
0.8978
|
0.2576
|
BioCarta//Hs_Sprouty regulation of tyrosine kinase signals
|
1/18 (31)
|
0.8978
|
0.2576
|
BioCarta//Hs_EGF Signaling Pathway
|
3/27 (54)
|
0.6372
|
0.2578
|
BioCarta//Hs_FAS signaling pathway ( CD95 )
|
3/30 (34)
|
0.7088
|
0.2584
|
BioCarta//Hs_PTEN dependent cell cycle arrest and apoptosis
|
2/18 (21)
|
0.6478
|
0.2591
|
BioCarta//Hs_EPO Signaling Pathway
|
2/19 (36)
|
0.6776
|
0.2592
|
BioCarta//Hs_Proteasome Complex
|
2/19 (24)
|
0.6776
|
0.2592
|
BioCarta//Hs_Complement Pathway
|
1/19 (33)
|
0.9101
|
0.2600
|
BioCarta//Hs_Stat3 Signaling Pathway
|
1/8 (13)
|
0.6359
|
0.2603
|
BioCarta//Hs_Internal Ribosome entry pathway
|
1/8 (39)
|
0.6359
|
0.2603
|
BioCarta//Hs_Overview of telomerase protein component gene hTert Transcriptional Regulation
|
1/8 (20)
|
0.6359
|
0.2603
|
BioCarta//Hs_Shuttle for transfer of acetyl groups from mitochondria to the cytosol
|
1/8 (11)
|
0.6359
|
0.2603
|
BioCarta//Hs_The Citric Acid Cycle
|
1/8 (9)
|
0.6359
|
0.2603
|
BioCarta//Hs_Calcium Signaling by HBx of Hepatitis B virus
|
1/8 (8)
|
0.6359
|
0.2603
|
BioCarta//Hs_RNA polymerase III transcription
|
1/8 (22)
|
0.6359
|
0.2603
|
BioCarta//Hs_The role of FYVE-finger proteins in vesicle transport
|
1/7 (35)
|
0.5868
|
0.2616
|
BioCarta//Hs_Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expression
|
1/4 (7)
|
0.3962
|
0.2616
|
BioCarta//Hs_Malate-aspartate shuttle
|
1/4 (8)
|
0.3962
|
0.2616
|
BioCarta//Hs_Function of SLRP in Bone: An Integrated View
|
1/4 (4)
|
0.3962
|
0.2616
|
BioCarta//Hs_West Nile Virus
|
1/4 (4)
|
0.3962
|
0.2616
|
BioCarta//Hs_Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine
|
1/4 (4)
|
0.3962
|
0.2616
|
BioCarta//Hs_Transcriptional activation of dbpb from mRNA
|
1/4 (9)
|
0.3962
|
0.2616
|
BioCarta//Hs_Eicosanoid Metabolism
|
1/20 (20)
|
0.9208
|
0.2620
|
BioCarta//Hs_Ion Channels and Their Functional Role in Vascular Endothelium
|
3/20 (20)
|
0.4283
|
0.2630
|
BioCarta//Hs_Fc Epsilon Receptor I Signaling in Mast Cells
|
4/38 (49)
|
0.6764
|
0.2631
|
BioCarta//Hs_Biosynthesis of neurotransmitters
|
1/6 (6)
|
0.5311
|
0.2636
|
BioCarta//Hs_Low-density lipoprotein (LDL) pathway during atherogenesis
|
1/6 (10)
|
0.5311
|
0.2636
|
BioCarta//Hs_Wnt/LRP6 Signalling
|
1/6 (25)
|
0.5311
|
0.2636
|
BioCarta//Hs_Metabolism of Anandamide, an Endogenous Cannabinoid
|
1/6 (13)
|
0.5311
|
0.2636
|
BioCarta//Hs_Circadian Rhythms
|
1/6 (13)
|
0.5311
|
0.2636
|
BioCarta//Hs_TSP-1 Induced Apoptosis in Microvascular Endothelial Cell
|
1/6 (9)
|
0.5311
|
0.2636
|
BioCarta//Hs_SUMOylation as a mechanism to modulate CtBP-dependent gene responses
|
1/6 (11)
|
0.5311
|
0.2636
|
BioCarta//Hs_Regulation of Spermatogenesis by CREM
|
1/6 (14)
|
0.5311
|
0.2636
|
BioCarta//Hs_Activation of cAMP-dependent protein kinase, PKA
|
1/6 (10)
|
0.5311
|
0.2636
|
BioCarta//Hs_Ceramide Signaling Pathway
|
1/21 (21)
|
0.9303
|
0.2637
|
BioCarta//Hs_METS affect on Macrophage Differentiation
|
2/16 (30)
|
0.5819
|
0.2645
|
BioCarta//Hs_Regulation of transcriptional activity by PML
|
2/16 (24)
|
0.5819
|
0.2645
|
BioCarta//Hs_Multi-step Regulation of Transcription by Pitx2
|
2/16 (38)
|
0.5819
|
0.2645
|
BioCarta//Hs_IL-7 Signal Transduction
|
2/16 (29)
|
0.5819
|
0.2645
|
BioCarta//Hs_The Co-Stimulatory Signal During |